Cerdak SRL
Cerdak reported total assets of 103,436 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Cerdak shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cerdak's annual accounts
| 2025 | |
|---|---|
| Net result | −48,491 € |
| Equity | −48,491 € |
| Cash | 11,812 € |
| EBITDA | −45,265 € |
| Total assets | 103,436 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
Cerdak's financial analysis
- Solvency-46.9%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cerdak
Cerdak's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1009.990.130
- VAT number
- BE1009990130
- Peppol
- Registered · 0208:1009990130 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jun 2024
- Registered office
- 3620 Lanaken
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Cerdak (SRL) has been based in Lanaken since 2024, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 48,491 € and equity of −48,491 €; its revenue is not published. Its solvency stands at -46.9%, below the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cerdak
Companies in the same business, of comparable size and area, outside its group.
- Floriphar Diagnostic imaging services and medical laboratory activities Waterloo · balance sheet 113,104 €
- Galenus Inc. Wholesale of pharmaceutical and medical goods Olen · balance sheet 126,374 €
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Labman Wholesale of pharmaceutical and medical goods Torhout · balance sheet 102,667 €
- Belgiophar Wholesale of other food Anderlecht · balance sheet 106,855 €
- Kolibrie Veterinair Distributiecentrum Wholesale of pharmaceutical and medical goods Beringen · balance sheet 56,858 €
- Calluna Pharma Manufacture of basic pharmaceutical products Hoogstraten · balance sheet 73,235 €
- Dentaal Labo Degraeve Diagnostic imaging services and medical laboratory activities Roeselare · balance sheet 140,896 €
Frequently asked questions about Cerdak
What is the revenue of Cerdak?
Cerdak files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cerdak?
In Belgium, the VAT number is the company number prefixed with BE: BE1009990130 for Cerdak, if the company is VAT-registered. Its company number (CBE) is 1009.990.130.
Where is the registered office of Cerdak?
According to the CBE register, the registered office of Cerdak is in 3620 Lanaken.
What is the equity of Cerdak?
At the close of the 2025 financial year, the equity of Cerdak amounts to -48,491 €, a solvency of -46.9% of total assets.
Who manages Cerdak?
The register lists 1 active mandates at Cerdak. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cerdak
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →